RxDoctor Payments Data

Colin Stair, MD

Interventional Pain Medicine · Summit, WINPI 1659766525

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (49.2%), grants and travel and lodging — rather than concentrated in one kind of arrangement. Medtronic accounts for 66.8% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2019 at $8,947 and has fallen 80.9% since, to $1,708 in 2025.

$16,708in general payments, 2019–2025

Across 129 payments — averaging $129.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$11K
  • SPR Therapeutics, Inc$1K
  • Boston Scientific$1K
  • Nevro Corp.$756
  • Pacira Pharmaceuticals Incorporated$677
  • Abbott$642
  • plus $852 from 7 others

What the payments were for

  • Grants$7,50045%
  • Travel & lodging$9856%
  • Food & beverage$8,22349%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,708 in reported general payments places this provider in the 85th percentile of 41 interventional pain medicine providers in Wisconsin.

See all interventional pain medicine providers in Wisconsin

Medicare billing

Part B allowed, 2024
$94,721
Medicare patients
263
Services billed
954

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin62$1,309
Pregabalin31$478
Tizanidine Hcl25$387
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen42$214
Methylprednisolone16$105
Meloxicam21$103
Tramadol Hcl13$99
Cyclobenzaprine Hcl12$97

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Summit

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →